Vaccination against Rotavirus Infections

Czech version

Authors: H. Ambrožová
Authors‘ workplace: 1. infekční klinika UK 2. LF a FN Na Bulovce, Praha
Published in: Čes-slov Pediat 2008; 63 (10): 594-598.
Category: Actual Topic

Sources

1. Van Damme P. Evidence –⁠ based recommendation for the use of rotavirus vaccines in Europe. 25th Annual Meeting of the European Society for Pediatric Infectious Diseases, Porto, May 2–4, 2007. Book of Abstracts, str. 3.

2. Vesicari T, Van Damme P, Giaquinto C, et al. European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenterology, Hepatology and Nutrition Evidence –⁠ based recommendations for rotavirus vaccination in Europe. J. Ped. Gast. Nutr. 2008;166(Suppl 2): S38–S48.

3. Giaquinto C, Van Damme P, Huet F, et al. Clinical consequences of rotavirus acute gastroenteritis in Europe, 2004–2005: The REVEAL Study. J. Infect. Dis. 2007;195: S26–S35.

4. Montse Soriano-Gabarró, Mrukowicz J, et al. Burden of rotavirus disease in European Union countries. Ped. Infect. Dis. J. 2006;25: S7–11.

5. Van Damme P, Giaquinto C, Huet F, et al. Multicenter prospective study of the burden of rotavirus acute gastroentreritis in Europe, 2004–2005: The REVEAL Study. J. Infect. Dis. 2007;195(Suppl 1): S4–S16.

6. Giaquinto C, Van Damme P, Huet F, et al. Costs of community –⁠ acquired pediatric rotavirus gastroenteritis in 7 European countries: The REVEAL Study. J. Infect. Dis. 2007;195(Suppl 1): S36–S44.

7. EPIDAT 2007. Praha: CME SZÚ.

8. Glezies O, Desselberger U, Tatochenko V, et al. Nosocomial rotavirus infection in European countries. A review of the epidemiology, severity and economic burden of hospital acquired rotavirus diseases. Ped. Infect. Dis. J. 2006;25: S12–21.

9. Richardson S, Grimwood K. Extended excretion of rotavirus after severe diarrhoea in young children. Lancet 1998;351 : 1844–1888.

10. Vesikari T, Giaquinto C, Huppertz H. Clinical trials of rotavirus vaccines in Europe. Ped. Infect. Dis. J. 2006;25: S42–S47.

11. Souhrn údajů o přípravku, SPC Rotarix, datum revize textu 21. 2. 2006.

12. Goveia NM, Rodriguez ZM, Dallas MJ, et al. Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants. Ped. Inf. Dis. J. 2007;12 : 1099–1104.

13. Vesikari T, Mason DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. New Engl. J. Med. 2006;354 : 23–33.

14. Souhrn údajů o přípravku, SC Rota Teq, datum revize textu 24. 7. 2007.